Stock comparison
Jeena Sikho Lifecare Limited
JSLL.BO$71.28BHealthcare Market cap, Sector
TG Therapeutics
TGTX$8.26BHealthcare Market cap, Sector
Overall winner
Jeena Sikho Lifecare Limited
JSLL.BO 61 TGTX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
JSLL.BO6wins
1winsTGTX
84B
D49
87A
C61
92A
D54
66C
B80
75B
C64
91A
D52
95A
F44
Side-by-side metrics
| Metric | JSLL.BO | TGTX |
|---|---|---|
| Market cap | Winner: $71.28B | $8.26B |
| P/E (TTM) | 33.2x | 12.4x Winner |
| EV/EBIT | Winner: 24.1x | 51.8x |
| ROIC (TTM) | Winner: 39.15% | 11.13% |
| Gross margin | Winner: 88.58% | 83.04% |
| Net margin | 27.68% | 65.95% Winner |
| Revenue CAGR 5y | 57.81% | 2.1% Winner |
| EPS CAGR 5y | 86.67% | - |
| Debt / Equity | Winner: 0.3x | 1.3x |
| Dividend yield | - | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
JSLL.BO leads on
- Market cap$71.28Bvs $8.26B+88%
- Debt / Equity0.3xvs 1.3x+79%
- ROIC (TTM)39.15%vs 11.13%+72%
- EV/EBIT24.1xvs 51.8x+53%
TGTX leads on
- Revenue CAGR 5y2.1%vs 57.81%+72%
- P/E (TTM)12.4xvs 33.2x+63%
- Net margin65.95%vs 27.68%+58%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.